Topic: Compassionate Use

President Trump received an 8-gram dose of Regeneron's experimental antibody cocktail under the FDA's "compassionate use" provision. The treatment, which is still in clinical trials, aims to lower viral levels significantly within days. While some patients report a miraculous return of taste and smell, critics express concern over potential side effects and the lack of long-term safety data for the unapproved drug.